Zentalis Pharmaceuticals, Inc. ZNTL
NASDAQ · United States · Health Technology
$2.52-0.08 (-3.26%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.59 | -0.49 | -20.4% | $0 | — | -14.7%$4.95→$4.22 |
| Q1 2026 | 2026-05-12 | -0.50 | -0.49 | -2.0% | — | — | +3.4%$4.14→$4.28 |
| Q4 2025 | 2026-03-26 | -0.49 | -0.61 | +19.7% | — | — | -17.6%$2.55→$2.10 |
| Q3 2025 | 2025-11-10 | -0.37 | -0.48 | +22.9% | — | — | +9.4%$1.28→$1.40 |
| Q1 2025 | 2025-05-14 | -0.67 | -0.61 | -9.8% | — | — | — |
| Q4 2024 | 2025-03-25 | -0.61 | -0.68 | +10.3% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.56 | -0.87 | +35.6% | — | — | — |
| Q2 2024 | 2024-08-09 | -1.24 | -0.83 | -49.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.